nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP1A2—Carmustine—malignant glioma	0.0986	0.569	CbGbCtD
Olanzapine—CYP3A4—Temozolomide—malignant glioma	0.0745	0.43	CbGbCtD
Olanzapine—HTR1D—meninx—malignant glioma	0.0299	0.0694	CbGeAlD
Olanzapine—HTR3A—fourth ventricle—malignant glioma	0.0291	0.0676	CbGeAlD
Olanzapine—HTR1B—dura mater—malignant glioma	0.0284	0.066	CbGeAlD
Olanzapine—HTR1D—dura mater—malignant glioma	0.0275	0.0639	CbGeAlD
Olanzapine—HTR2C—choroid plexus—malignant glioma	0.0232	0.0538	CbGeAlD
Olanzapine—DRD3—telencephalic ventricle—malignant glioma	0.0122	0.0283	CbGeAlD
Olanzapine—HTR2A—choroid plexus—malignant glioma	0.0116	0.027	CbGeAlD
Olanzapine—ORM1—vertebral column—malignant glioma	0.0091	0.0211	CbGeAlD
Olanzapine—DRD1—telencephalic ventricle—malignant glioma	0.00873	0.0203	CbGeAlD
Olanzapine—Clozapine—CALY—malignant glioma	0.00714	0.712	CrCbGaD
Olanzapine—HTR1B—telencephalic ventricle—malignant glioma	0.00707	0.0164	CbGeAlD
Olanzapine—HTR1D—telencephalic ventricle—malignant glioma	0.00685	0.0159	CbGeAlD
Olanzapine—HTR2C—telencephalic ventricle—malignant glioma	0.00678	0.0158	CbGeAlD
Olanzapine—HTR7—pons—malignant glioma	0.00663	0.0154	CbGeAlD
Olanzapine—HTR2A—cerebellar cortex—malignant glioma	0.00585	0.0136	CbGeAlD
Olanzapine—HTR1A—telencephalic ventricle—malignant glioma	0.00571	0.0133	CbGeAlD
Olanzapine—HTR7—telencephalic ventricle—malignant glioma	0.00546	0.0127	CbGeAlD
Olanzapine—DRD2—telencephalic ventricle—malignant glioma	0.00516	0.012	CbGeAlD
Olanzapine—HTR5A—central nervous system—malignant glioma	0.00478	0.0111	CbGeAlD
Olanzapine—HTR2A—pons—malignant glioma	0.00413	0.00961	CbGeAlD
Olanzapine—HTR2A—vertebral column—malignant glioma	0.0041	0.00953	CbGeAlD
Olanzapine—HTR1E—brainstem—malignant glioma	0.00405	0.0094	CbGeAlD
Olanzapine—HTR5A—brain—malignant glioma	0.0038	0.00882	CbGeAlD
Olanzapine—HTR1E—telencephalon—malignant glioma	0.00359	0.00834	CbGeAlD
Olanzapine—HTR1B—blood vessel—malignant glioma	0.0035	0.00813	CbGeAlD
Olanzapine—HTR2A—telencephalic ventricle—malignant glioma	0.0034	0.0079	CbGeAlD
Olanzapine—HTR1D—blood vessel—malignant glioma	0.00339	0.00788	CbGeAlD
Olanzapine—HTR2A—pineal body—malignant glioma	0.00295	0.00686	CbGeAlD
Olanzapine—HTR7—endothelium—malignant glioma	0.00293	0.0068	CbGeAlD
Olanzapine—HTR6—telencephalon—malignant glioma	0.00282	0.00655	CbGeAlD
Olanzapine—DRD5—telencephalon—malignant glioma	0.00274	0.00637	CbGeAlD
Olanzapine—HTR7—blood vessel—malignant glioma	0.0027	0.00627	CbGeAlD
Olanzapine—H1F0—embryo—malignant glioma	0.00261	0.00606	CbGeAlD
Olanzapine—DRD1—brainstem—malignant glioma	0.00236	0.00549	CbGeAlD
Olanzapine—H1F0—retina—malignant glioma	0.00231	0.00536	CbGeAlD
Olanzapine—HTR3A—brainstem—malignant glioma	0.00228	0.0053	CbGeAlD
Olanzapine—H1F0—telencephalon—malignant glioma	0.00212	0.00493	CbGeAlD
Olanzapine—DRD1—telencephalon—malignant glioma	0.0021	0.00487	CbGeAlD
Olanzapine—HTR1E—central nervous system—malignant glioma	0.00204	0.00474	CbGeAlD
Olanzapine—HTR3A—telencephalon—malignant glioma	0.00202	0.0047	CbGeAlD
Olanzapine—HTR1B—brainstem—malignant glioma	0.00191	0.00445	CbGeAlD
Olanzapine—DRD4—brain—malignant glioma	0.00188	0.00437	CbGeAlD
Olanzapine—HTR1D—brainstem—malignant glioma	0.00185	0.00431	CbGeAlD
Olanzapine—HTR2C—brainstem—malignant glioma	0.00184	0.00426	CbGeAlD
Olanzapine—HTR2A—endothelium—malignant glioma	0.00183	0.00424	CbGeAlD
Olanzapine—CHRM4—central nervous system—malignant glioma	0.00179	0.00416	CbGeAlD
Olanzapine—HTR1B—telencephalon—malignant glioma	0.0017	0.00395	CbGeAlD
Olanzapine—CHRM2—telencephalon—malignant glioma	0.00169	0.00393	CbGeAlD
Olanzapine—HTR2A—blood vessel—malignant glioma	0.00168	0.00391	CbGeAlD
Olanzapine—H1F0—medulla oblongata—malignant glioma	0.00167	0.00388	CbGeAlD
Olanzapine—DRD3—central nervous system—malignant glioma	0.00166	0.00387	CbGeAlD
Olanzapine—FMO3—central nervous system—malignant glioma	0.00165	0.00382	CbGeAlD
Olanzapine—HTR1D—telencephalon—malignant glioma	0.00164	0.00382	CbGeAlD
Olanzapine—HTR2C—telencephalon—malignant glioma	0.00163	0.00378	CbGeAlD
Olanzapine—HTR1E—brain—malignant glioma	0.00162	0.00377	CbGeAlD
Olanzapine—Amoxapine—SLC6A3—malignant glioma	0.00162	0.162	CrCbGaD
Olanzapine—HTR6—central nervous system—malignant glioma	0.0016	0.00372	CbGeAlD
Olanzapine—DRD5—central nervous system—malignant glioma	0.00156	0.00362	CbGeAlD
Olanzapine—HTR1A—brainstem—malignant glioma	0.00154	0.00359	CbGeAlD
Olanzapine—CHRM1—telencephalon—malignant glioma	0.00154	0.00357	CbGeAlD
Olanzapine—HTR2B—telencephalon—malignant glioma	0.00153	0.00355	CbGeAlD
Olanzapine—H1F0—midbrain—malignant glioma	0.00152	0.00354	CbGeAlD
Olanzapine—DRD1—midbrain—malignant glioma	0.00151	0.0035	CbGeAlD
Olanzapine—H1F0—spinal cord—malignant glioma	0.00149	0.00346	CbGeAlD
Olanzapine—HTR7—brainstem—malignant glioma	0.00148	0.00343	CbGeAlD
Olanzapine—HRH2—central nervous system—malignant glioma	0.00146	0.0034	CbGeAlD
Olanzapine—ADRA1A—brainstem—malignant glioma	0.00142	0.00331	CbGeAlD
Olanzapine—CHRM4—brain—malignant glioma	0.00142	0.0033	CbGeAlD
Olanzapine—CHRM5—central nervous system—malignant glioma	0.0014	0.00325	CbGeAlD
Olanzapine—DRD2—brainstem—malignant glioma	0.0014	0.00324	CbGeAlD
Olanzapine—CHRM3—telencephalon—malignant glioma	0.00138	0.0032	CbGeAlD
Olanzapine—HTR1A—telencephalon—malignant glioma	0.00137	0.00318	CbGeAlD
Olanzapine—DRD2—retina—malignant glioma	0.00135	0.00313	CbGeAlD
Olanzapine—DRD3—brain—malignant glioma	0.00132	0.00307	CbGeAlD
Olanzapine—HTR7—telencephalon—malignant glioma	0.00131	0.00304	CbGeAlD
Olanzapine—FMO3—brain—malignant glioma	0.00131	0.00303	CbGeAlD
Olanzapine—HTR2C—medulla oblongata—malignant glioma	0.00128	0.00297	CbGeAlD
Olanzapine—ADRA1B—central nervous system—malignant glioma	0.00128	0.00297	CbGeAlD
Olanzapine—HTR6—brain—malignant glioma	0.00127	0.00295	CbGeAlD
Olanzapine—ORM1—spinal cord—malignant glioma	0.00127	0.00295	CbGeAlD
Olanzapine—ADRA1A—telencephalon—malignant glioma	0.00126	0.00294	CbGeAlD
Olanzapine—Loxapine—SLC6A3—malignant glioma	0.00126	0.126	CrCbGaD
Olanzapine—DRD2—telencephalon—malignant glioma	0.00124	0.00288	CbGeAlD
Olanzapine—DRD5—brain—malignant glioma	0.00124	0.00288	CbGeAlD
Olanzapine—HTR1B—midbrain—malignant glioma	0.00122	0.00283	CbGeAlD
Olanzapine—H1F0—central nervous system—malignant glioma	0.00121	0.0028	CbGeAlD
Olanzapine—ADRA2C—telencephalon—malignant glioma	0.0012	0.0028	CbGeAlD
Olanzapine—DRD1—central nervous system—malignant glioma	0.00119	0.00277	CbGeAlD
Olanzapine—HTR1B—spinal cord—malignant glioma	0.00119	0.00277	CbGeAlD
Olanzapine—HTR1D—midbrain—malignant glioma	0.00118	0.00274	CbGeAlD
Olanzapine—H1F0—cerebellum—malignant glioma	0.00118	0.00274	CbGeAlD
Olanzapine—HTR2C—midbrain—malignant glioma	0.00117	0.00272	CbGeAlD
Olanzapine—HRH2—brain—malignant glioma	0.00116	0.0027	CbGeAlD
Olanzapine—HTR3A—central nervous system—malignant glioma	0.00115	0.00267	CbGeAlD
Olanzapine—HTR2C—spinal cord—malignant glioma	0.00114	0.00265	CbGeAlD
Olanzapine—CHRM5—brain—malignant glioma	0.00111	0.00258	CbGeAlD
Olanzapine—ABCB1—blood vessel—malignant glioma	0.0011	0.00256	CbGeAlD
Olanzapine—ORM1—central nervous system—malignant glioma	0.00103	0.00239	CbGeAlD
Olanzapine—HTR7—medulla oblongata—malignant glioma	0.00103	0.00239	CbGeAlD
Olanzapine—ADRA1B—brain—malignant glioma	0.00101	0.00236	CbGeAlD
Olanzapine—HTR2A—embryo—malignant glioma	0.001	0.00233	CbGeAlD
Olanzapine—HTR1A—midbrain—malignant glioma	0.000984	0.00229	CbGeAlD
Olanzapine—HRH1—telencephalon—malignant glioma	0.000978	0.00227	CbGeAlD
Olanzapine—HTR1B—central nervous system—malignant glioma	0.000966	0.00224	CbGeAlD
Olanzapine—ADRA2A—telencephalon—malignant glioma	0.000961	0.00223	CbGeAlD
Olanzapine—HTR1A—spinal cord—malignant glioma	0.00096	0.00223	CbGeAlD
Olanzapine—CHRM2—central nervous system—malignant glioma	0.00096	0.00223	CbGeAlD
Olanzapine—H1F0—brain—malignant glioma	0.000958	0.00223	CbGeAlD
Olanzapine—ADRA2C—medulla oblongata—malignant glioma	0.000946	0.0022	CbGeAlD
Olanzapine—DRD1—brain—malignant glioma	0.000946	0.0022	CbGeAlD
Olanzapine—HTR7—midbrain—malignant glioma	0.000941	0.00219	CbGeAlD
Olanzapine—HTR1D—central nervous system—malignant glioma	0.000935	0.00217	CbGeAlD
Olanzapine—HTR2C—central nervous system—malignant glioma	0.000926	0.00215	CbGeAlD
Olanzapine—HTR2A—brainstem—malignant glioma	0.000921	0.00214	CbGeAlD
Olanzapine—HTR7—spinal cord—malignant glioma	0.000918	0.00213	CbGeAlD
Olanzapine—HTR3A—brain—malignant glioma	0.000914	0.00212	CbGeAlD
Olanzapine—DRD2—midbrain—malignant glioma	0.000889	0.00207	CbGeAlD
Olanzapine—HTR2A—retina—malignant glioma	0.000888	0.00206	CbGeAlD
Olanzapine—CHRM1—central nervous system—malignant glioma	0.000874	0.00203	CbGeAlD
Olanzapine—HTR2B—central nervous system—malignant glioma	0.00087	0.00202	CbGeAlD
Olanzapine—ADRA2C—midbrain—malignant glioma	0.000865	0.00201	CbGeAlD
Olanzapine—ADRA2C—spinal cord—malignant glioma	0.000844	0.00196	CbGeAlD
Olanzapine—CYP2D6—brainstem—malignant glioma	0.000839	0.00195	CbGeAlD
Olanzapine—HTR2A—telencephalon—malignant glioma	0.000817	0.0019	CbGeAlD
Olanzapine—CHRM3—central nervous system—malignant glioma	0.000782	0.00182	CbGeAlD
Olanzapine—HTR1A—central nervous system—malignant glioma	0.000779	0.00181	CbGeAlD
Olanzapine—HTR1B—brain—malignant glioma	0.000767	0.00178	CbGeAlD
Olanzapine—CHRM2—brain—malignant glioma	0.000762	0.00177	CbGeAlD
Olanzapine—HTR1A—cerebellum—malignant glioma	0.000762	0.00177	CbGeAlD
Olanzapine—ADRA2A—medulla oblongata—malignant glioma	0.000755	0.00175	CbGeAlD
Olanzapine—HTR7—central nervous system—malignant glioma	0.000745	0.00173	CbGeAlD
Olanzapine—CYP2D6—telencephalon—malignant glioma	0.000744	0.00173	CbGeAlD
Olanzapine—HTR1D—brain—malignant glioma	0.000742	0.00172	CbGeAlD
Olanzapine—HTR2C—brain—malignant glioma	0.000735	0.00171	CbGeAlD
Olanzapine—HTR7—cerebellum—malignant glioma	0.000728	0.00169	CbGeAlD
Olanzapine—ADRA1A—central nervous system—malignant glioma	0.000718	0.00167	CbGeAlD
Olanzapine—ALB—brain—malignant glioma	0.000717	0.00167	CbGeAlD
Olanzapine—DRD2—central nervous system—malignant glioma	0.000704	0.00164	CbGeAlD
Olanzapine—ADRA1A—cerebellum—malignant glioma	0.000702	0.00163	CbGeAlD
Olanzapine—CHRM1—brain—malignant glioma	0.000694	0.00161	CbGeAlD
Olanzapine—HTR2B—brain—malignant glioma	0.00069	0.0016	CbGeAlD
Olanzapine—ADRA2A—midbrain—malignant glioma	0.00069	0.0016	CbGeAlD
Olanzapine—DRD2—cerebellum—malignant glioma	0.000688	0.0016	CbGeAlD
Olanzapine—ADRA2C—central nervous system—malignant glioma	0.000684	0.00159	CbGeAlD
Olanzapine—ADRA2A—spinal cord—malignant glioma	0.000673	0.00156	CbGeAlD
Olanzapine—ADRA2C—cerebellum—malignant glioma	0.000669	0.00155	CbGeAlD
Olanzapine—ABCB1—embryo—malignant glioma	0.000658	0.00153	CbGeAlD
Olanzapine—HTR2A—medulla oblongata—malignant glioma	0.000642	0.00149	CbGeAlD
Olanzapine—CHRM3—brain—malignant glioma	0.000621	0.00144	CbGeAlD
Olanzapine—HTR1A—brain—malignant glioma	0.000619	0.00144	CbGeAlD
Olanzapine—HTR7—brain—malignant glioma	0.000591	0.00137	CbGeAlD
Olanzapine—HTR2A—midbrain—malignant glioma	0.000587	0.00136	CbGeAlD
Olanzapine—ABCB1—retina—malignant glioma	0.000582	0.00135	CbGeAlD
Olanzapine—HTR2A—spinal cord—malignant glioma	0.000572	0.00133	CbGeAlD
Olanzapine—ADRA1A—brain—malignant glioma	0.00057	0.00132	CbGeAlD
Olanzapine—DRD2—brain—malignant glioma	0.000559	0.0013	CbGeAlD
Olanzapine—HRH1—central nervous system—malignant glioma	0.000556	0.00129	CbGeAlD
Olanzapine—ADRA2A—central nervous system—malignant glioma	0.000546	0.00127	CbGeAlD
Olanzapine—ADRA2C—brain—malignant glioma	0.000543	0.00126	CbGeAlD
Olanzapine—ABCB1—telencephalon—malignant glioma	0.000535	0.00124	CbGeAlD
Olanzapine—ADRA2A—cerebellum—malignant glioma	0.000534	0.00124	CbGeAlD
Olanzapine—HTR2A—central nervous system—malignant glioma	0.000464	0.00108	CbGeAlD
Olanzapine—HTR2A—cerebellum—malignant glioma	0.000454	0.00105	CbGeAlD
Olanzapine—HRH1—brain—malignant glioma	0.000441	0.00103	CbGeAlD
Olanzapine—ADRA2A—brain—malignant glioma	0.000434	0.00101	CbGeAlD
Olanzapine—CYP3A4—central nervous system—malignant glioma	0.00043	0.000999	CbGeAlD
Olanzapine—CYP2D6—central nervous system—malignant glioma	0.000423	0.000983	CbGeAlD
Olanzapine—ABCB1—medulla oblongata—malignant glioma	0.000421	0.000977	CbGeAlD
Olanzapine—CYP2D6—cerebellum—malignant glioma	0.000413	0.000961	CbGeAlD
Olanzapine—ABCB1—midbrain—malignant glioma	0.000384	0.000893	CbGeAlD
Olanzapine—ABCB1—spinal cord—malignant glioma	0.000375	0.000871	CbGeAlD
Olanzapine—HTR2A—brain—malignant glioma	0.000369	0.000856	CbGeAlD
Olanzapine—CYP2D6—brain—malignant glioma	0.000336	0.00078	CbGeAlD
Olanzapine—ABCB1—central nervous system—malignant glioma	0.000304	0.000707	CbGeAlD
Olanzapine—ABCB1—cerebellum—malignant glioma	0.000297	0.000691	CbGeAlD
Olanzapine—ABCB1—brain—malignant glioma	0.000242	0.000561	CbGeAlD
Olanzapine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	9.91e-06	2.56e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—KRAS—malignant glioma	9.89e-06	2.56e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	9.87e-06	2.56e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	9.87e-06	2.55e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—malignant glioma	9.86e-06	2.55e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL2—malignant glioma	9.85e-06	2.55e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EGFR—malignant glioma	9.84e-06	2.55e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	9.83e-06	2.54e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	9.8e-06	2.54e-05	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	9.79e-06	2.53e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	9.78e-06	2.53e-05	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	9.77e-06	2.53e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	9.77e-06	2.53e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CG—malignant glioma	9.76e-06	2.53e-05	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	9.74e-06	2.52e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—malignant glioma	9.73e-06	2.52e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	9.73e-06	2.52e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—malignant glioma	9.72e-06	2.52e-05	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	9.71e-06	2.51e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—malignant glioma	9.7e-06	2.51e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL2—malignant glioma	9.69e-06	2.51e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—malignant glioma	9.68e-06	2.51e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CG—malignant glioma	9.68e-06	2.5e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL2—malignant glioma	9.67e-06	2.5e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—malignant glioma	9.66e-06	2.5e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—malignant glioma	9.65e-06	2.5e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL2—malignant glioma	9.64e-06	2.49e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—malignant glioma	9.62e-06	2.49e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	9.62e-06	2.49e-05	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	9.62e-06	2.49e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL2—malignant glioma	9.61e-06	2.49e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	9.6e-06	2.48e-05	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	9.59e-06	2.48e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	9.53e-06	2.47e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—malignant glioma	9.53e-06	2.47e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL2—malignant glioma	9.51e-06	2.46e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	9.5e-06	2.46e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL2—malignant glioma	9.49e-06	2.46e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	9.49e-06	2.46e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	9.48e-06	2.45e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—malignant glioma	9.45e-06	2.45e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—STAT3—malignant glioma	9.44e-06	2.44e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—KRAS—malignant glioma	9.42e-06	2.44e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PPARG—malignant glioma	9.42e-06	2.44e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—STAT3—malignant glioma	9.39e-06	2.43e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTP1—malignant glioma	9.35e-06	2.42e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PPARG—malignant glioma	9.34e-06	2.42e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CD—malignant glioma	9.33e-06	2.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—malignant glioma	9.32e-06	2.41e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—malignant glioma	9.3e-06	2.41e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—KRAS—malignant glioma	9.3e-06	2.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PTEN—malignant glioma	9.27e-06	2.4e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	9.22e-06	2.39e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	9.22e-06	2.39e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	9.18e-06	2.38e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—malignant glioma	9.18e-06	2.38e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—malignant glioma	9.17e-06	2.37e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—malignant glioma	9.15e-06	2.37e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	9.13e-06	2.36e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—malignant glioma	9.12e-06	2.36e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PTEN—malignant glioma	9.12e-06	2.36e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CD—malignant glioma	9.11e-06	2.36e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAT—malignant glioma	9.1e-06	2.36e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PTEN—malignant glioma	9.1e-06	2.35e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—malignant glioma	9.09e-06	2.35e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	9.09e-06	2.35e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MYC—malignant glioma	9.08e-06	2.35e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CAV1—malignant glioma	9.08e-06	2.35e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	9.08e-06	2.35e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PTEN—malignant glioma	9.07e-06	2.35e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CB—malignant glioma	9.06e-06	2.34e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AKT1—malignant glioma	9.04e-06	2.34e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PTEN—malignant glioma	9.04e-06	2.34e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—malignant glioma	9e-06	2.33e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	8.99e-06	2.33e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	8.98e-06	2.32e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—malignant glioma	8.98e-06	2.32e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PTEN—malignant glioma	8.95e-06	2.32e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	8.93e-06	2.31e-05	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	8.91e-06	2.31e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	8.89e-06	2.3e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	8.89e-06	2.3e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—malignant glioma	8.88e-06	2.3e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—malignant glioma	8.88e-06	2.3e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	8.85e-06	2.29e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	8.83e-06	2.28e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	8.82e-06	2.28e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—malignant glioma	8.82e-06	2.28e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—malignant glioma	8.79e-06	2.27e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—malignant glioma	8.77e-06	2.27e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	8.73e-06	2.26e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—malignant glioma	8.72e-06	2.26e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	8.71e-06	2.25e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.67e-06	2.24e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	8.66e-06	2.24e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—malignant glioma	8.62e-06	2.23e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NCOR1—malignant glioma	8.6e-06	2.22e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CD—malignant glioma	8.58e-06	2.22e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—malignant glioma	8.58e-06	2.22e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	8.54e-06	2.21e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—malignant glioma	8.53e-06	2.21e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CD—malignant glioma	8.51e-06	2.2e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—malignant glioma	8.49e-06	2.2e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	8.39e-06	2.17e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—malignant glioma	8.38e-06	2.17e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—malignant glioma	8.37e-06	2.17e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—malignant glioma	8.35e-06	2.16e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	8.34e-06	2.16e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	8.3e-06	2.15e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	8.29e-06	2.15e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—malignant glioma	8.29e-06	2.14e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—malignant glioma	8.27e-06	2.14e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—malignant glioma	8.26e-06	2.14e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	8.23e-06	2.13e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—malignant glioma	8.22e-06	2.13e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—malignant glioma	8.22e-06	2.13e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—malignant glioma	8.21e-06	2.12e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	8.19e-06	2.12e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	8.17e-06	2.11e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	8.16e-06	2.11e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—malignant glioma	8.15e-06	2.11e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—malignant glioma	8.15e-06	2.11e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—malignant glioma	8.14e-06	2.11e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CB—malignant glioma	8.13e-06	2.1e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—malignant glioma	8.11e-06	2.1e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—malignant glioma	8.1e-06	2.1e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	8.09e-06	2.09e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	8.09e-06	2.09e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—malignant glioma	8.08e-06	2.09e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	8.06e-06	2.09e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—malignant glioma	8.06e-06	2.09e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—malignant glioma	8.06e-06	2.09e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—malignant glioma	8.01e-06	2.07e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—malignant glioma	7.98e-06	2.07e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	7.98e-06	2.07e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARG—malignant glioma	7.98e-06	2.07e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CB—malignant glioma	7.94e-06	2.05e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—malignant glioma	7.87e-06	2.04e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—malignant glioma	7.86e-06	2.03e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	7.84e-06	2.03e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—malignant glioma	7.83e-06	2.03e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—malignant glioma	7.75e-06	2.01e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	7.72e-06	2e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	7.71e-06	2e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—malignant glioma	7.7e-06	1.99e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—malignant glioma	7.63e-06	1.97e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—malignant glioma	7.58e-06	1.96e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—malignant glioma	7.56e-06	1.96e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—malignant glioma	7.54e-06	1.95e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—malignant glioma	7.53e-06	1.95e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—malignant glioma	7.51e-06	1.94e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—malignant glioma	7.5e-06	1.94e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	7.49e-06	1.94e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CB—malignant glioma	7.48e-06	1.94e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—malignant glioma	7.46e-06	1.93e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	7.44e-06	1.93e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—malignant glioma	7.44e-06	1.93e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—malignant glioma	7.42e-06	1.92e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—malignant glioma	7.42e-06	1.92e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	7.42e-06	1.92e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CB—malignant glioma	7.42e-06	1.92e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—malignant glioma	7.41e-06	1.92e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—malignant glioma	7.41e-06	1.92e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	7.41e-06	1.92e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—malignant glioma	7.39e-06	1.91e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—malignant glioma	7.37e-06	1.91e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—malignant glioma	7.35e-06	1.9e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—malignant glioma	7.35e-06	1.9e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—malignant glioma	7.28e-06	1.88e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CD—malignant glioma	7.27e-06	1.88e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	7.26e-06	1.88e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	7.2e-06	1.86e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—malignant glioma	7.2e-06	1.86e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—malignant glioma	7.17e-06	1.85e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—malignant glioma	7.11e-06	1.84e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	7.09e-06	1.83e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—malignant glioma	7.07e-06	1.83e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—malignant glioma	7.04e-06	1.82e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—malignant glioma	7.03e-06	1.82e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAV1—malignant glioma	7.01e-06	1.81e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—malignant glioma	7e-06	1.81e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—malignant glioma	7e-06	1.81e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—malignant glioma	6.99e-06	1.81e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—malignant glioma	6.98e-06	1.81e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—malignant glioma	6.97e-06	1.8e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—malignant glioma	6.96e-06	1.8e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—malignant glioma	6.94e-06	1.8e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—malignant glioma	6.89e-06	1.78e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—malignant glioma	6.87e-06	1.78e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—malignant glioma	6.86e-06	1.78e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—malignant glioma	6.86e-06	1.77e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	6.85e-06	1.77e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	6.74e-06	1.74e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	6.54e-06	1.69e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—malignant glioma	6.46e-06	1.67e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	6.43e-06	1.66e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	6.42e-06	1.66e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—malignant glioma	6.41e-06	1.66e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	6.4e-06	1.66e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.38e-06	1.65e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	6.38e-06	1.65e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	6.37e-06	1.65e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CB—malignant glioma	6.34e-06	1.64e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—malignant glioma	6.32e-06	1.64e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	6.31e-06	1.63e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	6.3e-06	1.63e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	6.3e-06	1.63e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—malignant glioma	6.28e-06	1.62e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—malignant glioma	6.23e-06	1.61e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—malignant glioma	6.22e-06	1.61e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—malignant glioma	6.21e-06	1.61e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—malignant glioma	6.19e-06	1.6e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—malignant glioma	6.17e-06	1.6e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARG—malignant glioma	6.16e-06	1.59e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—malignant glioma	6.11e-06	1.58e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—malignant glioma	6.09e-06	1.58e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—malignant glioma	6.08e-06	1.57e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—malignant glioma	6.05e-06	1.57e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	5.88e-06	1.52e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	5.85e-06	1.51e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	5.79e-06	1.5e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—malignant glioma	5.72e-06	1.48e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—malignant glioma	5.66e-06	1.46e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.61e-06	1.45e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—malignant glioma	5.52e-06	1.43e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—malignant glioma	5.48e-06	1.42e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—malignant glioma	5.34e-06	1.38e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—malignant glioma	5.25e-06	1.36e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—malignant glioma	5.24e-06	1.36e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—malignant glioma	5.23e-06	1.35e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—malignant glioma	5.21e-06	1.35e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—malignant glioma	5.16e-06	1.34e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	5.14e-06	1.33e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.96e-06	1.28e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.89e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—malignant glioma	4.85e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—malignant glioma	4.84e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	4.78e-06	1.24e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.56e-06	1.18e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.52e-06	1.17e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—malignant glioma	4.51e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—malignant glioma	4.23e-06	1.09e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—malignant glioma	4.05e-06	1.05e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—malignant glioma	3.95e-06	1.02e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—malignant glioma	3.86e-06	1e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—malignant glioma	3.73e-06	9.64e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—malignant glioma	3.69e-06	9.56e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—malignant glioma	3.16e-06	8.17e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.98e-06	7.72e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—malignant glioma	2.44e-06	6.3e-06	CbGpPWpGaD
